Intermediate coronary artery stenosis: Evidence-based decisions in interventions to avoid the oculostenotic reflex

International Journal of Cardiovascular Interventions

Volumn 3, Issue 4, 2000, Pages 195-206

  Patil, C V ^a   Beyar, R ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Coronary flow reserve; Coronary pressure measurement; Fractional flow reserve; Oculostenotic reflex; Percutaneous transluminal coronary angioplasty

Indexed keywords

ANGIOCARDIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY PRESSURE; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; GUIDE WIRE; HUMAN; MEDICAL DECISION MAKING; PREVALENCE; PRIORITY JOURNAL; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION;

EID: 0034511975     PISSN: 14628848     EISSN: None     Source Type: Journal    
DOI: 10.1080/14628840050515948     Document Type: Review

References (128)

1. Assessment of stenosis in coronary angioplasty: Inter and intraobserver variability
2. Interobserver variability in coronary angiography
3. Variability in the analysis of the coronary angiograms
4. Discrepancies between cineangiographic and postmortem findings in patients with coronary artery disease and recent myocardial revascularization
5. Correlation of the antemortem coronary angiogram and the post-mortem specimen
6. Coronary artery narrowing in coronary heart disease: Comparison of cineangiographic and necropsy findings
7. Guidelines for percutaneous transluminal coronary angioplasty
8. Analysis of coronary angioplasty practice in the United States with an insurance-claims database
9. Cine coronary arteriography
10. Effects of coronary stenosis on coronary flow reserve and resistance
11. Relation between myocardial blood flow and the severity of coronary artery stenosis
12. Relation between geometric dimensions of coronary artery stenoses and myocardial perfusion reserve in man
13. 201TI imaging and coronary angiography
14. Intracoronary doppler guidewire versus stress single photon emission computed tomographic Thallium-201 imaging in assessment of intermediate coronary stenoses
15. Coronary physiology revisited: Practical insights from the cardiac catheterization laboratory
16. Lumen narrowing after percutaneous transluminal coronary balloon angioplasty nears a Gaussian distribution: A quantitative angiographic study in 1445 successfully dilated lesions
17. Coronary artery dimensions from cineangiograms - Methodology and validation of a computer-assisted analysis procedure
18. Automated quantitative coronary angiography: Morphologic and physiologic validation in vivo of a rapid digital angiographic method
19. On line quantification of coronary angiograms with the DCI system
20. A new approach for the quantification of complex lesion morphology: The gradient field transform; basic principles and validation results
21. Accuracy and reliability of quantitative measurement of coronary arterial stenosis by videodensitometry on coronary angiogram
22. Quantitative measurements of balloon-to-artery ratios in coronary angioplasty
23. Reproducibility of measurements of coronary narrowings by videodensitometry and by digital calipers
24. Quantitative coronary angiography in the estimation of the functional significance of coronary stenosis: Correlations with dobutamine-atropine stress test
25. Variability of coronary flow reserve obtained immediately after coronary angioplasty
26. Qualitative and quantitative angiography
27. Coronary artery revascularization - Critical need for, and consequences of, objective angiographic assessment of lesion severity
28. Our preoccupation with coronary luminology - The dissociation between clinical and angiographic findings in ischemic heart disease
29. The accuracy of arteriography and ultrasound imaging for atherosclerosis measurement: A review
30. Radiographic principles in cardiac catheterization
31. Evaluation of stenosis severity: Quantitative angiography, coronary flow reserve, and intravascular ultrasound
32. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with omega-3 fatty acids
33. Comparison by quantitative angiographic assessment of coronary stenosis of one view showing the severest narrowing to two orthogonal views
34. Comparison of pifedinine propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris
35. Accuracy of angiographic determination of left main coronary arterial narrowing
36. Detection of unrecognized LMCA disease by intravascular ultrasound in patients undergoing interventions: Prevalence and severity
37. Coronary angioplasty for acute myocardial infarction
38. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction
39. Immediate versus delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction: TIMI II A results
40. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: No additional benefits from immediate percutaneous transluminal coronary angioplasty
41. Randomized comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
42. Benestent II, a remake of Benestent I? Or a step towards the era of stentoplasty?
43. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenosis after thrombolytic therapy of myocardial infarction
44. Long term follow up after percutaneous transluminal coronary angioplasty: The early Zurich experience
45. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
46. Randomized placebo-controlled and balloon angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. The EPISTENT investigators. Evaluation of platelet IIb/IIIa inhibitor for stenting
47. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease
48. The ARTS (Arterial Revascularization Therapies Study): Backgrounds, goals and methods
49. The metabolic demand and oxygen supply of the heart: Physiologic and clinical considerations
50. Evaluation of myocardial blood flow and metabolism
51. Prediction of the physiologic significance of coronary arterial lesions by quantitative lesion geometry in patients with limited coronary artery disease
52. Coronary vasodilator reserve after human orthotopic cardiac transplantation
53. Effects of coronary bypass surgery and angioplasty on coronary blood flow and flow reserve
54. Measurement of coronary flow reserve: Defining pathophysiology versus making decisions about patient care
55. Determinants of transstenotic gradients observed during angioplasty: An experimental model
56. Interventional physiology rounds: Translesional pressure-flow velocity assessment in patients
57. From research to clinical practice: Current role of intracoronary physiologically based decision making in the cardiac catheterization laboratory
58. Trans-stenotic coronary pressure gradient measurements in humans: In vitro and in vivo evaluation of a new pressure monitoring angioplasty guidewire
59. Validation of a doppler guide wire for intravascular measurement of coronary artery flow velocity
60. Initial experience with a miniaturized pressure transducer during coronary angioplasty
61. Fractional velocity reserve - A new index for stenosis severity assessment with good correlation to fractional flow reserve
62. Assessing the hemodynamic significance of coronary artery stenosis: Analysis of translesional pressure-flow relations in patients
63. Alterations of phasic coronary artery flow velocity in man during percutaneous coronary angioplasty
64. Analysis of flow characteristics in poststenotic regions of the human coronary artery during bypass graft surgery
65. Simultaneous coronary pressure and flow velocity measurements in humans: Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve
66. The significance of coronary reserve in clinical heart disease
67. Which variable of stenosis severity best describes the significance of an isolated left anterior descending coronary artery lesion? Correlation between quantitative coronary angiography, intracoronary doppler measurements and high dose dipyridamole echocardiography
68. 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenosis
69. Correlations between coronary flow reserve measured with doppler guide wire and treadmill exercise testing
70. Angiographic and doppler flow-derived parameters for assessment of coronary lesion severity and its relation to the result of exercise electrocardiography
71. Diagnostic value of exercise electrocardiography and thallium myocardial scintigraphy in patients without previous myocardial infarction: A bayesian approach
72. Physiology basis for assessing critical coronary stenosis: Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve
73. Coronary hemodynamics during PTCA
74. In vitro and in vivo evaluation of a new 0.015″ fluid-filled guide wire for distal pressure monitoring during PTCA
75. Coronary wedge pressure in relation to spontaneously visible and recruitable collaterals
76. Is the residual translesional pressure gradient useful to predict regional myocardial perfusion after percutaneous transluminal coronary angioplasty?
77. Percutaneous transluminal coronary angioplasty: Ten years' experience
78. Potential protective effect of high coronary wedge pressure on left ventricular function after coronary occlusion
79. The concept of maximal flow ratio for immediate evaluation of percutaneous transluminal coronary angioplasty result by videodensitometry
80. Experimental basis of determining maximum coronary, myocardial and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous tranluminal coronary angioplasty
81. Measurement of fractional flow reserve to assess the functional severity of coronary artery stenosis
82. Quantification of recruitable coronary collateral blood flow in conscious humans and its potential to predict future ischemic events
83. Functional measures of coronary stenosis severity at cardiac catheterization
84. Functional assessment of coronary stenosis: It does make sense, but why don't I do it more often?
85. Practice and potential pitfalls of coronary pressure measurement
86. Fractional flow reserve: A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow
87. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise induced myocardial ischemia
88. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve
89. Comparison of exercise electrocardiography with invasively assessed myocardial fractional flow reserve in evaluation of severity of coronary arterial narrowing
90. Coronary flow reserve calculated from pressure measurements in humans - Validation with positron emission tomography
91. Maximal coronary flow and the concept of coronary vascular reserve
92. Effects of cardiac hypertrophy secondary to hypertension on the coronary circulation
93. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test
94. To measure pressure for pleasure - Or is intracoronary pressure gauging pressing?
95. Atherosclerosis in angiographically 'normal' coronary artery reference segments: An intravascular ultrasound study with clinical correlations
96. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance
97. In-hospital and 1-month clinical results of an international study testing the concept of IVUS guided optimized stent expansion alleviating the need of systemic anticoagulation
98. Early and late quantitative angiographic outcomes in the Optimal Atherectomy Restenosis Study (OARS)
99. Clinical and angiographic follow-up of Adjunctive Balloon Angioplasty following Coronary Atherectomy Study (ABACAS)
100. Results of high-pressure ultrasound-guided 'oversized' balloon PTCA to achieve 'stent-like' results
101. Small stent size and intimal hyperplasia contribute to restenosis: A volumetric intravascular ultrasound analysis
102. Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study
103. Chronic arterial responses to stent implantation: A serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries
104. Unrecognized left main coronary artery disease in patients undergoing interventional procedures
105. Intravascular ultrasound to assess left main stem coronary artery lesion
106. Comparison of quantitative coronary angiography, intravascular ultrasound, and coronary pressure measurement to assess optimum stent deployment
107. Role of coronary artery lumen enlargement in improving coronary blood flow after balloon angioplasty and stenting: A combined intravascular ultrasound Doppler flow and imaging study
108. Improvement of coronary morphology and blood flow after stenting: Assessment by intravascular ultrasound and intracoronary Doppler
109. Clinical potential of intravascular ultrasound for physiological assessment of coronary stenosis: Relationship between quantitative ultrasound tomography and pressure-derived fractional flow reserve
110. Clinical, intravascular ultrasound, and quantitative angiographic determinants of the coronary flow reserve before and after percutaneous transluminal coronary angioplasty
111. Relation between single tomographic intravascular ultrasound image parameters and intracoronary Doppler flow velocity in patients with intermediately severe coronary stenoses
112. Hypolipidemic intervention and plaque stabilization
113. Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease
114. Conner memorial lecture: Mechanisms leading to myocardial infarction: Insights from studies of vascular biology
115. Atherosclerosis: Inhibition or regression as therapeutic possibilities
116. Coronary angioplasty versus medical therapy for angina: The second Randomized Intervention Treatment of Angina (RITA-2) trial
117. Deferral versus performance of PTCA based on coronary pressure derived fractional flow reserve: The DEFER study
118. Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements
119. Safety of deferring angioplasty in patients with normal coronary flow velocity reserve
120. Long term follow up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement
121. Physiologic assessment of coronary stenoses of intermediate severity can facilitate patient selection for coronary angioplasty?
122. Deferring angioplasty in intermediate coronary lesions based on coronary flow criteria is safe: Comparison of a deferred group to an intervention group
123. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty. The DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe)
124. DEBATE II: Final results of the 6-month follow-up
125. The French Optimal Stenting Trial (FROST): A multicenter, prospective randomized study comparing systematic stenting to angiography/coronary flow reserve guided stenting: 6 month clinical and angiographic follow-up
126. Doppler and QCA guided aggressive PTCA has the same target lesion revascularization of stent implantation: 6-month-results of the DESTINI study
127. Clinical, angiographic and physiologic predictors of major adverse cardiac events (MACE) after stent implantation